Colin Sauder

Colin Sauder currently serves as the Chief Scientific Officer at Adams Clinical, a position held since March 2025. Previously, Colin Sauder was the Head of Late Clinical Science in Neuropsychiatry and Executive Director of Clinical Development at Bristol Myers Squibb from March 2024 to March 2025. Prior experience includes roles as Executive Director, Clinical Development, Senior Director, and Director of Clinical Scientist at Karuna Therapeutics from June 2020 to March 2024. Earlier positions at Adams Clinical from June 2017 to May 2020 involved serving as Scientific Director/Principal Investigator and Director of Recruitment. Colin Sauder began academic work as an Assistant Professor in the Department of Psychiatry at UT Health San Antonio from July 2014 to 2017. Educational credentials include a Ph.D. in Clinical Psychology from Stony Brook University (2015), a Master’s in Clinical Child Psychology from the University of Washington (2010), and a Bachelor of Arts in Psychology from Brandeis University (2004).